Mandate

Vinge advises Amundi in connection with the acquisition of Lyxor Asset Management from Société Générale for EUR 825 million

Vinge has advised Amundi, a division of the Crédit Agricole group, in connection with its acquisition of Lyxor from Société Générale.

Lyxor is a pioneer within, and the third largest actor in Europe with regard to exchange‑traded funds (ETFs), and via this acquisition Amundi will thereby strengthen its position as the European lead actor in the fast‑growing market for ETFs. The transaction is subject to customary approvals by public authorities and is expected to be completed not later than February 2022.

Vinge’s team consisted of responsible partner Fredrik Wilkens (Project Manager), Henrik SchönAnton Sjökvist (Fund Issues), Åsa GotthardsonSara Strandberg and Ebba Svenburg (Employment Law), Maria Schultzberg, Henrik Wastenson and Karolin Ekström (Tax) as well as Ulf Nilsson (VAT).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025